Table 2.
|
|
|
|
Multivariate analyses |
||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Bivariate analyses |
Model 1a |
|
Model 2b |
||||||
Characteristics | Odds ratio (OR) | 95% CI | p-value | Odds ratio (OR) | 95% CI | p-value | Odds ratio (OR) | 95% CI | p-value | |
Gender | ||||||||||
Male | 1.00 | – | – | 1.00 | – | – | – | – | – | |
Female | 1.71 | 1.07–2.73 | 0.025 | 1.44 | 0.84–2.46 | 0.180 | – | – | – | |
Education | ||||||||||
High school or less | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | |
College | 1.45 | 0.84–2.47 | 0.179 | 1.66 | 0.93–2.99 | 0.088 | 1.46 | 0.80–2.68 | 0.216 | |
Graduate | 2.25 | 1.21–4.20 | 0.011 | 2.14 | 1.08–4.26 | 0.030 | 2.00 | 0.99–4.05 | 0.054 | |
Cancer type | ||||||||||
Breast | 1.00 | – | – | – | – | – | – | 1.00 | – | – |
Lung | 0.44 | 0.25–0.80 | 0.007 | – | – | – | – | 0.48 | 0.24–0.96 | 0.037 |
GI | 0.95 | 0.51–1.78 | 0.884 | – | – | – | – | 1.15 | 0.56–2.35 | 0.711 |
Other | 0.52 | 0.25–1.07 | 0.075 | – | – | – | – | 0.82 | 0.35–1.89 | 0.636 |
Surgery* | ||||||||||
No | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | |
Yes | 2.01 | 1.28–3.17 | 0.003 | 1.68 | 1.00–2.83 | 0.051 | 1.54 | 0.91–2.62 | 0.110 | |
Radiation* | ||||||||||
No | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | |
Yes | 1.53 | 0.98–2.40 | 0.063 | 1.61 | 0.98–2.67 | 0.062 | 1.81 | 1.07–3.05 | 0.026 | |
Chemotherapy* | ||||||||||
No | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | |
Yes | 1.72 | 0.81–3.64 | 0.160 | 2.37 | 1.01–5.56 | 0.047 | 2.97 | 1.22–7.22 | 0.016 | |
Survivorhsip status | ||||||||||
Post treatment | 1.00 | – | – | 1.00 | – | – | 1.00 | – | – | |
In treatment | 0.51 | 0.31–0.85 | 0.010 | 0.51 | 0.29–0.89 | 0.019 | 0.49 | 0.27–0.87 | 0.015 |
SPCS, supportive and palliative care services; OR, odds ratio; CI, confidence interval; GI, gastrointestinal.
Services used since cancer diagnosis.
Model 1 includes gender but not cancer type.
Model 2 includes cancer type but not gender.